The Premier Federal
Advocacy Firm for the
Cannabis Industry




Friday, March 23, 2018:  Late this evening, Congress finally passed the much anticipated FY2018 Omnibus Spending Bill that included the Rohrabacher-Blumenauer / Leahy Amendment language protecting the stakeholders in the 46 states who rely on medical Cannabis for their health and well being.  After multiple "stop-gap" measures enacted via Continuing Resolutions, licensed and lawfully operating medical stakeholders in the Cannabis Industry now have a legal certainty that they can operate without the threat of federal government interference following last Friday's vote.  With this long awaited Congressional action in place, TLG has begun diligent efforts to expand these protections to cover Adult/Recreational Use Cannabis stakeholders and address the much needed relief to enact level playing field legislation that ensures access to banking and equitable tax treatment for Industry.  

Thursday, January 4, 2018: Attorney General Jeff Sessions rescinded multiple  Department of Justice Guidance Memoranda, including the famous Cole Memorandum.  Since 2013, these Memoranda limited the federal government's interference by directing United States Attorneys to refrain from prosecuting licensed stakeholders and state programs under specific guidelines.  Click HERE for more details.  


The Liaison Group:  Cannabis Lobbying Firm in Washington, D.C.

The Liaison Group (TLG) is a DC-based federal lobbying firm dedicated to shaping the federal legislative and policy landscape for the Cannabis Industry.  TLG focuses its efforts and expertise in both the House and Senate with the overarching goal of protecting and preserving state-authorized Cannabis programs.  Our approach: 


Assess where each office is in their understanding of the Industry, the Cannabis Plant, and awareness of recent and current legislative efforts impacting Industry;


Identify the specific concerns of each office that influence their ability and willingness to support legislative efforts;


Educate offices on the modern applications and research of the Cannabis Plant, and serve as a resource on the dynamics within the Industry as well as on the Plant's benefits, efficacy and safety profile;


Influence Congressional Members and Staff on legislation by bridging a direct benefit between the legislation and their constituency, and articulating the consequences of inaction.


Advance and ultimately Change the laws that impact the entire Cannabis Industry by strategically navigating the current political climate, bringing unexpected allies into the fold, and leveraging unique windows of opportunity to advance legislative strategies.



The Liaison Group works to secure and sustain market access for businesses within the Cannabis Industry. The Liaison Group advocates for clients who believe that an Industry that values and is committed to compliance, via sound regulatory frameworks - that address finance and banking needs, manufacturing practices, labeling and packaging, and inventory and security measures - will flourish into a prosperous environment for all stakeholders.


Issue Advocacy:  TLG makes sure our Cannabis clients' voices and values are heard and understood by federal lawmakers.   By understanding the short, medium and long term Industry landscape, we not only succeed in raising awareness around evolving industry issues, but TLG helps change minds to deliver results.  

Government Relations & Lobbying:  TLG serves its clients as "eyes and ears" inside the beltway.  TLG combines its "boots on the ground" DC experience with prowess and poise to interface with decision-makers and policy influencers throughout the federal government.

Strategic Planning & Consulting:  Successfully and effectively communicating a message begins with a thoughtful, targeted and comprehensive plan.  TLG works closely with every client to ensure that their organization's vision aligns with their  government affairs and public policy initiatives to ultimately support their strategic goals.


Questions about working with us?